Nitric oxide synthase gene and protein expression are upregulated by Bacille Calmette-Guérin in the rat bladder

European Urology

Volumn 39, Issue 3, 2001, Pages 349-356

  Oh, Bong R ^a   Nakajima, Koichi ^b   Ahn, Kyu Y ^a   Ryu, Soo B ^a   Park, Yang I ^a   Dahiya, Rajvir ^c  

^a Chonnam National University Medical School   (South Korea)

^b TOHO UNIVERSITY   (Japan)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

BCG; Bladder; eNOS; iNOS; nNOS

Indexed keywords

BCG VACCINE; MESSENGER RNA; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER; BLADDER MUSCLE; CONTROLLED STUDY; ENDOTHELIUM; ENZYME REGULATION; FEMALE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BCG VACCINE; FEMALE; GENE EXPRESSION REGULATION; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION; URINARY BLADDER;

EID: 0035087543     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052466     Document Type: Article

References (32)

1. Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumors
2. Bacillus Calmette-Guérin immunotherapy for bladder cancer
3. BCG in perspective: Advances in the treatment of superficial bladder cancer
4. Effects of local bacillus Calmette-Guérin therapy in patients with bladder carcinoma on immunocompetent cells of bladder wall
5. Flad HD: Elevations of cytokines interleukin-1, interleukin-2 and tumor necrotic factor in the urine of patients after intravesical bacillus Calmette-Guérin immunotherapy
6. Neutrophil-activating peptide-1/interleukin-8 detection in human urine during acute bladder inflammation caused by transurethral resection of superficial cancer and bacillus Calmette-Guérin administration
7. Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumor necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer
8. Production of urinary tumor necrosis factors and soluble tumor necrosis factor receptors in bladder cancer patients after bacillus Calmette-Guérin immunotherapy
9. Nitric oxide synthase in mammals
10. The L-arginine-nitric oxide pathway
11. Mucin synthesis and secretion in various human epithelial cancer cell lines that express the MUC-1 mucin gene
12. Inhibition of tumorigenic potential and prostate-specific antigen expression in LNCaP human prostate cancer cell line by 13-cis-retinoic acid
13. DNA repair genes in human fetal and adult prostatic tissues and cancer cell lines using different RT-PCR
14. New approach to hot-start polymerase chain reaction using Taq DNA polymerase antibody
15. Optimal BCG treatment of superficial bladder cancer as defined by American trials
16. BCG immunotherapy of bladder cancer: 20 Years on
17. Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after bacillus Calmette-Guérin (BCG) immunotherapy
18. Urinary interleukins in patients receiving intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer
19. Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine: A molecular mechanism regulating cellular proliferation that targets intracellular iron
20. The role of nitric oxide in bacillus Calmette-Guérin mediated anti-tumor effects in human bladder cancer
21. Superficial bladder cancer: Decreasing the risk of recurrence
22. Effect of long term oral L-arginine on the nitric oxide synthase pathway in the urine from patients with interstitial cystitis
23. Urinary nitric oxide synthase activity and cyclic GMP levels are decreased with interstitial cystitis and increased with urinary tract infections
24. Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells
25. Hyperpermeability of intestinal epithelial monolayers is induced by NO: Effect of low extracellular pH
26. Nitric oxide synthesis inhibition increases epithelial permeability via mast cells
27. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease
28. Nitric oxide mediates the action of lipoteichoic acid on the function of human urothelial cells
29. The importance of a lipopolysaccharide-initiated, cytokine-mediated host defense mechanism in mice against extraintestinally invasive Escherichia coli
30. Nitric oxide is an important mediator for tumoricidal activity in vivo
31. Role of nitric oxide in pancreatic tumour growth: In vivo and in vitro studies
32. Studies of iron deposits, inducible nitric oxide synthase and nitrotyrosine in a rat model for esophageal adenocarcinoma